Company news

hVIVO plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

MHRA approval for nasal COVID-19 vaccine trial

December 14, 2020

Venn Life Sciences contract wins

December 7, 2020

Directors Change

November 24, 2020

Collaboration with HIC-VAC and Wellcome Trust

November 19, 2020

New £2.5m Influenza Challenge Study Contract Win

November 5, 2020

New 2-year contract with a tier 1 German company

October 30, 2020

Contract Signed with UK Government

October 20, 2020

Statement re further media comment

October 16, 2020

Interim Results for 6 months ended 30 June 2020

September 30, 2020

New £4.3m Challenge Study Contract Win

September 28, 2020

Statement re price movement and press speculation

September 24, 2020

Exercise of Investor Warrants and Issue of Shares

September 22, 2020

hVIVO present at 2020 ERS International Congress

September 7, 2020

Major New Contract Win with Top 3 Pharma Company

August 10, 2020

New Contract Win with Carna Bioscience ("Carna")

August 4, 2020

Contract for COVID-19 Vaccine Trial

July 28, 2020

Option to Acquire CHIMagents Limited

July 15, 2020

Upcoming Investor Events

July 8, 2020

Additional Laboratory Services Contracts Signed

July 7, 2020

Notice of AGM

June 26, 2020

Results for the year ended 31 December 2019

June 24, 2020

Open Orphan presenting at virtual Investor Foru...

June 17, 2020

Positive Phase I results published in The Lancet

June 15, 2020

Major New Contract Signed

June 11, 2020

Launch of Covid-19 Antibody Testing

June 4, 2020

Results of Fundraising

May 22, 2020

Update on antibody test and share price movement

May 18, 2020

Appointment of Joint Broker

May 11, 2020

Major New Contract and Directorate Change

May 4, 2020

Testing of anti-viral for treating COVID-19

April 23, 2020

Publication of positive results in journal

March 16, 2020

Publication of Positive Results in Journal

March 10, 2020

Completion of Compulsory Acquisition of Shares

March 9, 2020

New Contract

March 6, 2020

Change in Registered Office

March 2, 2020

Appointment of new Director

February 27, 2020

Result of Rule 15 Offer and Total Voting Rights

February 26, 2020

Investor Event Attendance and Presentation

February 21, 2020

Appointment of Chair of Advisory Board

February 20, 2020

Appointment of Group Chief Financial Officer

February 13, 2020

Value the Markets Webinar

February 10, 2020

Significant shareholder

February 7, 2020

Total Voting Rights

February 6, 2020

Exercise of Warrants and Issue of Shares

February 5, 2020

New Corporate Presentation

February 3, 2020

Results of Placing and Subscription

January 31, 2020

Compulsory Acquisition of Remaining hVIVO Shares

January 28, 2020

Update on Placing

January 23, 2020

Completion of Merger with hVIVO and Re-Admission

January 20, 2020

Rule 2.9 Announcement

January 17, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 18 calls. Every call is listed under its year.

Decks

The 5 newest of 16 decks. Every deck is listed under its year.